Dirk Brockstedt

Dirk Brockstedt

Company: RAPT Therapeutic

Job title: Chief Scientific Officer


RPT193 – A potent, selective oral CCR4 Antagonist for the treatment of Atopic Dermatitis 11:00 am

• Exploring the role of Th2 cells in atopic dermatitis and the contribution of CCR4-mediated Th2 migration to the disease • Introducing the RPT193, a novel oral CCR4 antagonist • Describing preclinical efficacy of RPT193 in various Th2 driven allergic disease mouse models • Description of the clinical development plan for RPT193Read more

day: Day 2 AM - Track 1

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.